Abstract A number of health economics studies require patient cost estimates as basic information input. However, the accuracy of cost estimates remains generally unspecified. We propose to investigate how the allocation of indirect costs or overheads can affect the estimation of patient costs and lead to improvements in the analysis of patient cost estimates. Instead of focussing on the costing method, this paper will highlight observed changes in variation explained by a methodology choice. We compare four overhead allocation methods for a specific Spanish population adjusted using the Clinical Risk Groups model. Our main conclusion is that the amount of global variation explained by the risk adjustment model depends mainly on direct costs, regardless of the cost allocation methodology used. Furthermore, the variation explained can be slightly increased, depending on the cost allocation methodology, and is independent of the level of aggregation in the classification system.
Introduction
An accurate estimation of costs is essential to many studies within the health economics spectrum. Taking into account that a universally accepted costing methodology has yet to be developed, the most appropriate methodology depends on the decision problem faced. We can distinguish two general approaches. A first method is used by economists to obtain real costs to society or opportunity costs. This method is related to measuring costs for decision making and is based on marginal analysis, usually in the long run, e.g. economic evaluations. The second method, which has a more specific perspective, comes from a particular organisation, usually a health service provider or a health service purchaser, and is related to measuring costs for price setting or financial planning, based on cost accounting analysis, usually in the short run.
Obtaining individual or patient costs remains a complex challenge and faces numerous obstacles. Bottom-up microcosting methodology refers to the most detailed patient-specific resource consumption measurement and is considered the gold standard in the economic evaluation literature. However, its implementation is expensive and time consuming [1] . According to Wordsworth et al. [2] bottom-up microcosting is the method of choice for labour costs and other cost components that have a great impact on total costs. Tan et al. [3] showed that the selection of a different methodology (top-down microcosting or bottomup gross costing) for labour costs and other critical cost components can produce differences in patient cost estimates. On the other hand, Clement et al. [4] investigated how selection of the costing methodology can affect the results of an economic evaluation and produce further wrong decisions. The health economics literature also considers the existence of missing data [5, 6] or the application of inadequate costing methods [7] in the analysis of individual healthcare costs.
Regardless of the methodological discussion above, the allocation of overheads is a problematic question that requires careful attention. Some studies analyse homogeneous patient groups using only direct (or marginal) costs [8, 9] . Conceptually, direct costs are related directly to the activity and, as a consequence, they are less susceptible to arbitrary allocation criteria [10] . However, the complete price of health services requires full absorption of costs. Unfortunately, there is a general lack of consensus about the appropriate costing methodology [10] [11] [12] , and some authors [13] even define the overhead allocation simply as ''a matter of judgement and common sense''.
The motivation for writing this article arose during the development of a research project published by Inoriza et al. [14] . The aim of the original project was to classify a specific patient population according to morbidity using the Clinical Risk Groups (CRG) model proposed by Hughes et al. [15] , and to obtain individual costs for them. Depending on the purpose, different costing methodologies should be used. Considering the scope of the project and the data available, a retrospective full absorption system was chosen as a suitable method. However, the implied overhead absorption and its effect in relation to the patient classification system remained a controversial point for the research team.
In connection with the above concern, this paper provides insights aimed at filling that lack of consensus in the literature by analysing the statistical effects caused by the allocation of indirect costs. Throughout the paper, the expression ''indirect costs'' is related to costs that are not directly accountable to the activity (company overheads or shared costs), unlike other accepted meanings in the health economics literature, such as productivity costs. Rather than focussing on the costing method, the main objective of our work was to observe whether the utilisation of a particular overhead allocation methodology can distort the predictive performance of a risk model. Taking a specific population, we test different cost allocation methodologies and obtain different series of group averages, from which we can measure the proportion of variation of total costs explained by the risk adjustment model (R 2 ). The information system used in our estimations is the CRG concurrent risk adjustment model presented by Hughes et al. [15] . The reason behind the choice of a concurrent (or retrospective) analysis is straightforward: to isolate the statistical effects caused by allocation of overheads without the statistical distortion produced by combining information from different years. In other words, we use individual morbidity information and patient costs from the year 2005 to obtain risk categories and cost weights for the same year. Furthermore, we check whether the R 2 coefficients from our concurrent model belong to a range of values comparable to other papers in the literature using the same information system (above 0.42).
The CRG properties have been widely described in the literature [15, 16] . However, whether cost modelling decisions can affect the CRG predictive performance has never been investigated.
The rest of this paper is organised as follows. After this Introduction the section (Data and methods) presents the data used and details of the different cost allocation methodologies. ''Results'' presents the results and, finally, ''Discussion'' draws conclusions.
Data and methods

Data
Serveis de Salut Integrats del Baix Empordà (SSIBE) is an integrated healthcare management organisation responsible for the public provision of health services-including primary care, specialised attention and acute hospitalisations-in the county of Baix Empordà in Catalonia (Spain). The total population in the Baix Empordà covered by SSIBE in 2005 was 90,849 individuals.
In order to control population, morbidity and costs, SSIBE runs an integrated patient database with individual information on morbidity (procedures, diagnostic codes, discharge data, ICD9-CM and other clinical information), service consumption (pharmaceutical and other products) and activity records.
Furthermore, the CRG system creates patient morbidity categories using all the information on diagnostics and procedures related to the population during a specific period. After 2005, the system processed 822,786 codes collected between 1 January 2005 and 31 December 2005 that were related to the 90,849 individuals included in the study.
The demographic characteristics and the risk profile of the population are shown in Table 1 , where we can observe that the population was distributed almost equally by gender (50.60% were males and 49.40% were females) and 68.32% of the population belonged to the category of healthy individuals.
Methods
We consider patient costs to be the objective of the analysis and define three different cost categories: patient or direct costs, departmental or semi-direct costs, and indirect costs or overheads. SSIBE business lines and cost structures are shown in Table 2 . Some company departments are not visible here because their cost had been charged to the final departments in a previous step (e.g. catering, laundry, pharmacy). Only 10.98% of total costs belong to the category of direct costs assigned to patients, and 42.24% correspond to the cost of main departments. The remaining total costs correspond mostly to support units (29.61%) and indirect costs (17.17%).
The costing methodology we used combined the bottom-up and the top-down approaches described in Mogyorosy and Smith [1] . Thus, we add up direct costs of patients stemming from their related clinical records and calculate other costs from the different company departments. During 2005, total expenses presented by the SSIBE financial accounts reached 45,868,690.45 € (including depreciation and financial expenses). In the following paragraphs we describe how the methodology deals with the different types of costs.
The first category of costs, direct costs (10.98% of the total expenditures), is obtained by a bottom-up approach as the sum of expenses related directly to patients. They include direct costs from blood transfusions, prostheses, intermediate products, and pharmaceutical consumption.
The second category of costs, departmental costs, represents the largest proportion of costs within the institution (71.85%), and includes costs of health services that can be charged to patients using average costs and individual patient data on use of services resources (top-down microcosting approach). Examples of costs recorded in this category are the number of hospital stays, laboratory tests or rehabilitation sessions.
Lastly, the third category of costs, indirect costs (representing 17.17% of total costs) includes company fixed costs such as management, accounting, building amortisation, and other costs not directly accountable to the activity. Unlike direct and departmental costs, indirect costs cannot be assigned directly to patients based on use. Therefore, we need to assign to each patient a fair proportion of the general overheads.
The health economics literature proposes different allocation methods. However, as mentioned before, there is no common agreement on which of these methodologies best allocates indirect costs. In this paper, we utilise and compare four different methods from the list of Bean and Hussey [11] : flat rate, output, actual utilisation and direct labour hours. 1 A brief description of each method is presented below:
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we have 13 different departments at our institution, general overheads are simply divided into 13 portions. 2. Output: under the output methodology, expenses are assigned proportionally to the different departments of the institution depending on the amount of services provided. Thus, general overheads are charged to each department according to the ratio of department output/global output. 3. Actual utilisation: proportional to the actual utilisation of overhead costs. Since every department has an initial amount of indirect costs, general overheads are divided proportionally to the ratio of initial department overheads/R initial departmental overheads. 4. Direct labour hours: Every department absorbs a portion of the general overheads according to the ratio of department direct labour hours/R departmental direct labour hours. Table 3 shows the overhead absorption scheme and the monetary value attached to activity units under the four methodologies. The first two are obviously unconvincing: with the flat rate method, every department absorbs a fixed amount of 605,655.96€, while with the output method the amount of overheads charged to every department depends on the sum of heterogeneous activities. However, both methods are included in order to compare how different cost allocation methodologies present in the literature perform.
We calculate estimates for the total cost associated to each individual using four different methodologies for allocating indirect costs, and consequently obtain four different vectors: Total Cost Flat Rate , Total Cost Output , Total Cost Actual Utilisation , Total Cost Direct labour hours . Furthermore, we use the CRG classification system to group patients according to their morbidity, obtaining a risk category for each individual. At this point, we need to compare four allocation strategies. The original work of Hughes et al. [15] predicts individual costs (the dependent variable) using cost averages from risk groups. Proceeding from this point of view, the best estimation of individual total costs will be produced by the strategy according to which group averages explain the greatest amount of individual variation. Therefore, we present and compare each cost allocation methodology using the same concurrent analysis presented in Hughes et al. [15] , providing information on the proportion of variation explained by each strategy through the R 2 coefficient.
Results
The CRG system allows individuals to be classified into mutually exclusive clinical categories according to their health status. This classification system presents 1,099 CRG categories, which can be grouped using four different levels of aggregation: ACRG1 (441 groups), ACRG2 (176 Table 4 presents direct average costs (column 2) and total average costs when an absorption hypothesis is chosen (columns 3-6). Looking at the results, output, actual utilisation and direct labour hours methodologies explain a very similar amount of variation. The proportion of variance explained by such models is very similar, approximately 2% higher than the risk adjustment model predicting only individual direct costs. However, the R 2 coefficient is slightly higher when using the output absorption method for allocating indirect costs. On the other hand, total cost averages generated by health status through the risk adjustment model are very close for output and actual utilisation methods. In contrast, the flat rate methodology differs greatly in terms of the variation explained because the model tends to charge unhealthy people with large average costs. Hence, comparing the flat rate methodology with the other methods, total average costs are greater for status 8 and 9 (the two worst health status). Furthermore, using the flat rate absorption, the variation explained is reduced with respect to the direct cost case.
As expected, using a more detailed scale (ACRG3, ACRG2, ACRG1 or CRG) increases the proportion of variation explained by the different methodologies in the concurrent model (when current expenditures are predicted through actual CRGs), obtaining an R 2 of about 0.40. Table 5 shows the relationship between R 2 and the aggregation level. We observe how the total amount of variance explained by the risk adjustment system depends mainly on the direct cost contribution, regardless of the level of aggregation. However, adding the allocation of indirect costs through the output, actual utilisation and direct labour hours methodologies increases the variation explained by about 2 percentage points.
Discussion
The need for accurate and quality individual cost estimates comes under the category overhead allocation, which is generally arbitrary. Moreover, as Bean and Hussey [11] and Lucey [13] have stated, the costing literature does not offer a clear solution for the allocation of overheads, even if the objective in the analysis is the relation between cost modelling and variation explained for a risk-adjusted population.
A first conclusion that can be drawn from the results is that the global amount of variation explained by the CRG depends mainly on direct costs. As shown in Table 4 , the allocation of overheads produces only a marginal change in the variation explained in comparison with using direct costs only. This conclusion can be interpreted in line with the results of Tan et al. [3] and Wordsworth et al. [2] in the sense that focussing on critical cost components with a large impact on total costs, usually classified as direct costs, the system will produce reliable cost estimates regardless of other related specifications. Therefore, the question asked in the title requires a negative answer: when the purpose of costing is to obtain patient costs, the variation explained by risk-group averages depends mainly on direct costs. Consequently, the selection of an overhead allocation methodology does not produce a significant distortion of results. In other words, patients with similar health conditions (included in the same CRG category) receive a similar amount of overheads, regardless of the overhead allocation methodology. The previous idea implies a second remarkable consideration. Although the variation explained depends on direct costs, using a reasonable costing methodology for allocating overheads, with the actual utilisation and direct labour hours methodologies being the most preferred, the total amount of variation explained can be increased. Table 5 shows how both methods produce a higher R 2 coefficient for all levels of aggregation; CRG (1,099 groups), ACRG1 (441 groups), ACRG2 (176 groups), ACRG3 (46 groups) and core health status rank (9 groups). It is important to emphasise that the gain in variance obtained is independent of the level of aggregation used in the risk adjustment system. Whereas the global amount of variation explained increases using a more detailed scale, from health status (R 2 = 0.20) to CRG (R 2 = 0.40), the gain in variance caused by the overhead allocation remains constant at about 2 percentage points.
The results obtained for the CRG aggregation level (R 2 = 0.40) are very similar to those obtained by Hughes et al. [15] for the concurrent model (R 2 = 0.42), and improve upon the results obtained for the same population on individual pharmaceutical consumption using a concurrent model by García-Goñi and Ibern [17] and García-Goñi et al. [22] (R 2 = 0.30 and R 2 = 0.23, respectively). Although the use of a concurrent analysis, without exploring prospective implications, is a limitation of the study, such a method seems to be a useful way to isolate the statistical effects produced by overhead allocation. The alternative is the prospective approach, but some statistical distortion would certainly be produced by combining information from different years.
The study also has other limitations: according to Carey and Burgess [18] , cost modelling decisions can be affected by many other factors not related to patient costs: the different needs that a cost system has to satisfy, the coexistence of a secondary costing system in the same company, or the presence of financial incentives addressed to obtain certain results [19] . Although general theoretical frameworks for analysing costs exist, e.g. Mogyorosy and Smith [1] or Fields et al. [20] , they lack the perspective from which our study is proposed. Another limitation arises from using only one risk assessment model. A study of the Society of Actuaries [21] evaluated 12 diagnosis and/or pharmacy based models: Adjustment Clinical Groups (ACGs) (2 versions), Chronic Illness and Disability Payment System (CDPS), Clinical Risk Groups (CRGs), Diagnostic Cost Groups (DCGs), Episode Risk Groups (ERGs), Impact Pro, MEDai, Medicaid Rx, Pharmacy Risk Groups (PRGs), Rx Groups Risk Smart and Underwriting Model Risk Smart. Investigating whether a similar hypothesis produces similar results for other important risk assessment models would be an interesting aspect of future research.
The properties of the CRG have been described accurately in works such as Hughes et al. [15] or Neff et al. [16] . Certain problems arising from building costs at the patient level have been discussed previously from a different perspective in the costing literature. Our work combines both approaches, exploring how the CRG predictive performance can be affected by a specific class of cost modelling decisions, i.e. those related to overhead allocation. 
